Soul Medicine Institute
Santa Rosa, California, 95403, United States
NCT Number: NCT00737399
Anxiety and depression have been found to be significant co-occurring conditions in cancer patients. This study examines these and other psychological conditions in patients diagnosed with cholangiocarcinoma, a rare cancer of the bile duct, with an average survival time of three to six months post-diagnosis. Participants are taught EFT in telephone and internet group coaching sessions, and have access to an online support forum. They complete the Mini-Mental Adjustment to Cancer Scale (Mini-MAC), EORTC Quality of Life scale, the PTSD checklist, the Patient Health Questionnaire, and a brief health checklist. Participants also provide medical records confirming their diagnosis, and markers, both before and after the study. The study is expected to enroll 20-15 cholangiocarcinoma patients, and use a within-subjects, time series, repeated measures design. Symptoms are assessed prior to coaching, after four, and again after eight weekly coaching sessions. Follow-ups will occur in one month, three months, and one year. It is hypothesized that a drop in the severity of co-occurring psychological symptoms, pain and insomnia may occur after EFT coaching.
This study is active but is not currently recruiting participants.
Notify Me18 year–89 year
All sexes
Interventional
Early Phase 1
Santa Rosa, California, 95403, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two series of four sessions of phone support group coaching instruction in the use of EFT
Time frame: duration of study
Time frame: duration of study
Time frame: duration of study
Time frame: duration of study
Soul Medicine Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01929720
Adnexal Diseases, Anxiety Disorder
Columbus, Ohio, United States
View Trial DetailsNCT07481903
Anxiety, Anxiety Disorders
Beijing, Beijing Municipality, China
View Trial DetailsNCT07117591
Anxiety Disorders, Behavior
Yozgat, Turkey (Türkiye)
View Trial DetailsNCT06644573
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Aventura, Florida, United States
View Trial Details